The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
Open accessAbstract
Integrins, a diverse class of heterodimeric cell surface receptors, are key regulators of cell structure and behaviour, affecting cell morphology, proliferation, survival and differentiation. Consequently, mutations in specific integrins, or their deregulated expression, are associated with a variety of diseases. In the last decades, many integrin-specific ligands have been developed and used for modulation of integrin function in medical as well as biophysical studies. The IC 50-values reported for these ligands strongly vary and are measured using different cell-based and cell-free systems. A systematic comparison of these values is of high importance for selecting the optimal ligands for given applications. In this study, we evaluate a wide range of ligands for their binding affinity towards the RGD-binding integrins αvβ3, αvβ5, αvβ6, αvβ8, α5β1, αIIbβ3, using homogenous ELISA-like solid phase binding assay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
Hersel, U., Dahmen, C., & Kessler, H. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00343-0 · Cited by 2,582
Self-citationEnvironmental sensing through focal adhesions
Geiger, B., Spatz, J. P., & Bershadsky, A. D. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2593 · Cited by 2,543
Self-citationIntegrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Xiong, J.-P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., & Arnaout, M. A. (2002) · Science · doi:10.1126/science.1069040 · Cited by 1,613
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., & Smith, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000003200 · Cited by 1,356
Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
Hynes, R. O., & Naba, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004903 · Cited by 1,349
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Crystal Structure of the Extracellular Segment of Integrin αVβ3
Xiong, J.-P., Stehle, T., Diefenbach, B., Zhang, R., Dunker, R., Scott, D. L., Joachimiak, A., Goodman, S. L., & Arnaout, M. A. (2001) · Science · doi:10.1126/science.1064535 · Cited by 1,276
Daynes, R. A., Araneo, B. A., Ershler, W. B., Maloney, C., Li, G. Z., & Ryu, S. Y. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5219 · Cited by 1,264
Takada, Y., Ye, X., & Simon, S. (2007) · Genome Biology · doi:10.1186/gb-2007-8-5-215 · Cited by 1,205
Activation of Integrin Function by Nanopatterned Adhesive Interfaces
Arnold, M., Cavalcanti‐Adam, E. A., Glass, R., Blümmel, J., Eck, W., Kantlehner, M., Kessler, H., & Spatz, J. P. (2004) · ChemPhysChem · doi:10.1002/cphc.200301014 · Cited by 1,164
Self-citationStupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Pytela, R., Pierschbacher, M. D., Ginsberg, M. H., Plow, E. F., & Ruoslahti, E. (1986) · Science · doi:10.1126/science.2420006 · Cited by 925
Conformation and Biological Activity of Cyclic Peptides
Kessler, H. (1982) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198205121 · Cited by 868
Self-citationPlotnikov, S. V., Pasapera, A. M., Sabass, B., & Waterman, C. M. (2012) · Cell · doi:10.1016/j.cell.2012.11.034 · Cited by 866
N -Methylated Cyclic RGD Peptides as Highly Active and Selective α V β 3 Integrin Antagonists
Dechantsreiter, M. A., Planker, E., Mathä, B., Lohof, E., Hölzemann, G., Jonczyk, A., Goodman, S. L., & Kessler, H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm970832g · Cited by 838
Self-citationIntegrin–TGF‐β crosstalk in fibrosis, cancer and wound healing
Margadant, C., & Sonnenberg, A. (2010) · The EMBO Reports · doi:10.1038/embor.2009.276 · Cited by 653
Mas-Moruno, C., Rechenmacher, F., & Kessler, H. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010794728639 · Cited by 647
Self-citationJuliano, R. L. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.090401.151133 · Cited by 597
Haubner, R., Gratias, R., Diefenbach, B., Goodman, S. L., Jonczyk, A., & Kessler, H. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9603721 · Cited by 582
Self-citationAumailley, M., Gurrath, M., Müller, G., Calvete, J., Timpl, R., & Kessler, H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81101-d · Cited by 551
Self-citationPfaff, M., Tangemann, K., Müller, B., Gurrath, M., Müller, G., Kessler, H., Timpl, R., & Engel, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31981-6 · Cited by 534
Self-citationZhu, J., Luo, B.-H., Xiao, T., Zhang, C., Nishida, N., & Springer, T. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.11.018 · Cited by 503
Haubner, R., Weber, W. A., Beer, A. J., Vabuliene, E., Reim, D., Sarbia, M., Becker, K.-F., Goebel, M., Hein, R., Wester, H.-J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020070 · Cited by 489
Self-citationKoivunen, E., Wang, B., & Ruoslahti, E. (1995) · Nature Biotechnology · doi:10.1038/nbt0395-265 · Cited by 477
Integrins as therapeutic targets: lessons and opportunities
Cox, D., Brennan, M., & Moran, N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3266 · Cited by 456
Haubner, R., Finsinger, D., & Kessler, H. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199713741 · Cited by 430
Self-citationThe Role of Thiols and Disulfides on Protein Stability
Trivedi, M., Laurence, J., & Siahaan, T. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630534 · Cited by 406
Integrin-based therapeutics: biological basis, clinical use and new drugs
Ley, K., Rivera-Nieves, J., Sandborn, W. J., & Shattil, S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.10 · Cited by 403
Integrins as therapeutic targets
Goodman, S. L., & Picard, M. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.04.002 · Cited by 376
Scarborough, R. M., Naughton, M. A., Teng, W., Rose, J. W., Phillips, D. R., Nannizzi, L., Arfsten, A., Campbell, A. M., & Charo, I. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54042-4 · Cited by 375
Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus.
Gan, Z. R., Gould, R. J., Jacobs, J. W., Friedman, P. A., & Polokoff, M. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77710-2 · Cited by 368
Therapeutic antagonists and conformational regulation of integrin function
Shimaoka, M., & Springer, T. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1174 · Cited by 349
Kantlehner, M., Schaffner, P., Finsinger, D., Meyer, J., Jonczyk, A., Diefenbach, B., Nies, B., Hölzemann, G., Goodman, S. L., & Kessler, H. (2000) · ChemBioChem · doi:10.1002/1439-7633(20000818)1:2<107::aid-cbic107>3.0.co;2-4 · Cited by 324
Self-citationNon-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors
Hartman, G. D., Egbertson, M. S., Halczenko, W., Laswell, W. L., Duggan, M. E., Smith, R. L., Naylor, A. M., Manno, P. D., & Lynch, R. J. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00102a020 · Cited by 301
A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence.
Dedhar, S., Ruoslahti, E., & Pierschbacher, M. D. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.3.585 · Cited by 297
Ligands for Mapping αvβ3-Integrin Expression in Vivo
Schottelius, M., Laufer, B., Kessler, H., & Wester, H.-J. (2009) · Accounts of Chemical Research · doi:10.1021/ar800243b · Cited by 294
Self-citationMeyer, A., Auernheimer, J., Modlinger, A., & Kessler, H. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947740 · Cited by 291
Self-citationKenny, L. M., Coombes, R. C., Oulie, I., Contractor, K. B., Miller, M., Spinks, T. J., McParland, B., Cohen, P. S., Hui, A.-M., Palmieri, C., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049452 · Cited by 280
Nabors, L. B., Fink, K. L., Mikkelsen, T., Grujicic, D., Tarnawski, R., Nam, D. H., Mazurkiewicz, M., Salacz, M., Ashby, L., Zagonel, V., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou356 · Cited by 242
Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor
Nagae, M., Re, S., Mihara, E., Nogi, T., Sugita, Y., & Takagi, J. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201111077 · Cited by 237
Tumor Targeting via Integrin Ligands
Marelli, U. K., Rechenmacher, F., Sobahi, T. R. A., Mas-Moruno, C., & Kessler, H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00222 · Cited by 236
Self-citationStoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parry, G. C., Parikh, A. A., McCarty, M. F., Bucana, C. D., Mazar, A. P., & Ellis, L. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10958 · Cited by 224
The RGD motif in fibronectin is essential for development but dispensable for fibril assembly
Takahashi, S., Leiss, M., Moser, M., Ohashi, T., Kitao, T., Heckmann, D., Pfeifer, A., Kessler, H., Takagi, J., Erickson, H. P., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703021 · Cited by 214
Self-citationSpontaneous Formation of L-Isoaspartate and Gain of Function in Fibronectin
Curnis, F., Longhi, R., Crippa, L., Cattaneo, A., Dondossola, E., Bachi, A., & Corti, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604812200 · Cited by 211
Solution stability of linear vs. cyclic RGD peptides
Bogdanowich‐Knipp, S. J., Chakrabarti, S., Siahaan, T. J., Williams, T. D., & Dillman, R. K. (1999) · The Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00052.x · Cited by 206
Nanomolar Small Molecule Inhibitors for αvβ6, αvβ5, and αvβ3 Integrins
Goodman, S. L., Hölzemann, G., Sulyok, G. A. G., & Kessler, H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0102598 · Cited by 196
Self-citationGaranger, E., Boturyn, D., & Dumy, P. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007781668706 · Cited by 185
Endothelial α5 and αv integrins cooperate in remodeling of the vasculature during development
van der Flier, A., Badu-Nkansah, K., Whittaker, C. A., Crowley, D., Bronson, R. T., Lacy-Hulbert, A., & Hynes, R. O. (2010) · Development · doi:10.1242/dev.049551 · Cited by 162
Solution Structures and Integrin Binding Activities of an RGD Peptide with Two Isomers
Assa‐Munt, N., Jia, X., Laakkonen, P. M., & Ruoslahti, E. I. (2001) · Biochemistry · doi:10.1021/bi002101f · Cited by 157
Definition of an Unexpected Ligand Recognition Motif for αvβ6 Integrin
Kraft, S., Diefenbach, B., Mehta, R., Jonczyk, A., Luckenbach, G. A., & Goodman, S. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1979 · Cited by 145
Hölig, P., Bach, M., Völkel, T., Nahde, T., Hoffmann, S., Müller, R., & Kontermann, R. E. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh055 · Cited by 129
αvβ3‐ or α5β1‐Integrin‐Selective Peptidomimetics for Surface Coating
Mas‐Moruno, C., Fraioli, R., Rechenmacher, F., Neubauer, S., Kapp, T. G., & Kessler, H. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509782 · Cited by 128
Self-citationRadioligand Binding Assays and Their Analysis
Maguire, J. J., Kuc, R. E., & Davenport, A. P. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-909-9_3 · Cited by 117
Auzzas, L., Zanardi, F., Battistini, L., et al. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790936301 · Cited by 103
Heckmann, D., Meyer, A., Marinelli, L., Zahn, G., Stragies, R., & Kessler, H. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700008 · Cited by 102
Self-citationPfaff, M., McLane, M. A., Beviglia, L., Niewiarowski, S., & Timpl, R. (1994) · Cell Communication & Adhesion · doi:10.3109/15419069409014213 · Cited by 99
Hamilton, A. M., Aidoudi-Ahmed, S., Sharma, S., Kotamraju, V. R., Foster, P. J., Sugahara, K. N., Ruoslahti, E. I., & Rutt, B. K. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1279-x · Cited by 98
Kessler, H., Gratias, R., Heßler, G., Gurrath, M., & Müller, G. (1996) · Pure and Applied Chemistry · doi:10.1351/pac199668061201 · Cited by 98
Self-citationStructure-Function Analysis of Arg-Gly-Asp Helix Motifs in αvβ6 Integrin Ligands
DiCara, D. M., Rapisarda, C., Sutcliffe-Goulden, J., Violette, S. M., Weinreb, P. H., Hart, I. R., Howard, M. J., & Marshall, J. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610461200 · Cited by 97
Rechenmacher, F., Neubauer, S., Polleux, J., Mas‐Moruno, C., Simone, M. D., Cavalcanti‐Adam, E. A., Spatz, J. P., Fässler, R., & Kessler, H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206370 · Cited by 95
Self-citationRational Design of Highly Active and Selective Ligands for the α5β1 Integrin Receptor
Heckmann, D., Meyer, A., Laufer, B., Zahn, G., Stragies, R., & Kessler, H. (2008) · ChemBioChem · doi:10.1002/cbic.200800045 · Cited by 89
Self-citationStrategies To Inhibit Tumor Associated Integrin Receptors: Rationale for Dual and Multi-Antagonists
Sheldrake, H. M., & Patterson, L. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000547 · Cited by 89
Alva, A. S., Slovin, S. F., Daignault, S. D., Carducci, M. A., DiPaola, R. S., Pienta, K. J., Agus, D. B., Cooney, K. A., Chen, A. P., Smith, D. C., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9573-5 · Cited by 88
Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6‐Selective Integrin Ligands
Maltsev, O. V., Marelli, U. K., Kapp, T. G., Leva, F. S. D., Maro, S. D., Nieberler, M., Reuning, U., Schwaiger, M., Novellino, E., Marinelli, L., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508709 · Cited by 80
Self-citationBochen, A., Marelli, U. K., Otto, E., Pallarola, D., Mas‐Moruno, C., Leva, F. S. D., Boehm, H., Spatz, J. P., Novellino, E., Kessler, H., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301221x · Cited by 76
Self-citationMultiple N-Methylation by a Designed Approach Enhances Receptor Selectivity
Chatterjee, J., Ovadia, O., Zahn, G., Marinelli, L., Hoffman, A., Gilon, C., & Kessler, H. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701044r · Cited by 76
Self-citationIntegrin modulators: a patent review
Kapp, T. G., Rechenmacher, F., Sobahi, T. R., & Kessler, H. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.818133 · Cited by 71
Self-citationInterface Immobilization Chemistry of cRGD‐based Peptides Regulates Integrin Mediated Cell Adhesion
Pallarola, D., Bochen, A., Boehm, H., Rechenmacher, F., Sobahi, T. R., Spatz, J. P., & Kessler, H. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201302411 · Cited by 68
Self-citationIncreasing αvβ3 Selectivity of the Anti‐Angiogenic Drug Cilengitide by N‐Methylation
Mas‐Moruno, C., Beck, J. G., Doedens, L., Frank, A. O., Marinelli, L., Cosconati, S., Novellino, E., & Kessler, H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201102971 · Cited by 67
Self-citationAntitumor effect of RGD-4C-GG-D(KLAKLAK)2 peptide in mouse B16(F10) melanoma model.
Smolarczyk, R., Cichoń, T., Graja, K., Hucz, J., Sochanik, A., & Szala, S. (2006) · Acta Biochimica Polonica · doi:10.18388/abp.2006_3309 · Cited by 63
Rechenmacher, F., Neubauer, S., Mas‐Moruno, C., Dorfner, P. M., Polleux, J., Guasch, J., Conings, B., Boyen, H. ‐., Bochen, A., Sobahi, T. R., et al. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201301478 · Cited by 61
Self-citationMogford, J. E., Davis, G. E., & Meininger, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119689 · Cited by 60
Šimeček, J., Notni, J., Kapp, T. G., Kessler, H., & Wester, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5000746 · Cited by 59
Self-citationSpatial Screening for the Identification of the Bioactive Conformation of Integrin Ligands
Weide, T., Modlinger, A., & Kessler, H. (2006) · Springer eBooks · doi:10.1007/128_052 · Cited by 57
Self-citationSelective Imaging of the Angiogenic Relevant Integrins α5β1 and αvβ3
Neubauer, S., Rechenmacher, F., Beer, A. J., Curnis, F., Pohle, K., D’Alessandria, C., Wester, H., Reuning, U., Corti, A., Schwaiger, M., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201306376 · Cited by 52
Self-citationInfluence of length and flexibility of spacers on the binding affinity of divalent ligands
Liese, S., & Netz, R. R. (2015) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.11.90 · Cited by 52
Eldred, C. D., Evans, B., Hindley, S. J., Judkins, B. D., Kelly, H. A., Kitchin, J. R., Lumley, P., Porter, B., & Ross, B. C. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00049a006 · Cited by 44
Pharmacophoric Modifications Lead to Superpotent αvβ3 Integrin Ligands with Suppressed α5β1 Activity
Neubauer, S., Rechenmacher, F., Brimioulle, R., Leva, F. S. D., Bochen, A., Sobahi, T. R., Schottelius, M., Novellino, E., Mas‐Moruno, C., Marinelli, L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500092w · Cited by 43
Self-citationHeckmann, D., Laufer, B., Marinelli, L., Limongelli, V., Novellino, E., Zahn, G., Stragies, R., & Kessler, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900206 · Cited by 41
Self-citationKapp, T. G., Fottner, M., Maltsev, O. V., & Kessler, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508713 · Cited by 30
Self-citationMüller, M. A., Opfer, J., Brunie, L., Volkhardt, L. A., Sinner, E., Boettiger, D. C., Bochen, A., Kessler, H., Gottschalk, K., & Reuning, U. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.05.020 · Cited by 26
Self-citationBecker, A., von Richter, O., Kovar, A., Scheible, H., van Lier, J. J., & Johne, A. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.482 · Cited by 23
Comparison of biological properties of 111In-labeled dimeric cyclic RGD peptides
Zheng, Y., Ji, S., Tomaselli, E., et al. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.10.005 · Cited by 14
Cilengitide restrains the osteoclast‐like bone resorbing activity of myeloma plasma cells
Tucci, M., Stucci, L. S., Felici, C., Cafforio, P., Resta, L., Rossi, R., & Silvestris, F. (2016) · British Journal of Haematology · doi:10.1111/bjh.13922 · Cited by 12
Human αvβ3 Integrin Potency and Specificity of TA138 and Its DOTA Conjugated Form (89)Y-TA138
Mousa, S. A., & Mohamed, S. N. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000151927.89154.9a · Cited by 4
Cited by
Nicolas, J., Magli, S., Rabbachin, L., Sampaolesi, S., Nicotra, F., & Russo, L. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00045 · Cited by 509
Exploring the Role of RGD-Recognizing Integrins in Cancer
Nieberler, M., Reuning, U., Reichart, F., Notni, J., Wester, H.-J., Schwaiger, M., Weinmüller, M., Räder, A., Steiger, K., & Kessler, H. (2017) · Cancers · doi:10.3390/cancers9090116 · Cited by 429
Self-citationFertala, A. (2020) · Bioengineering · doi:10.3390/bioengineering7040155 · Cited by 109
A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction
Sato, T., Verma, S., Andrade, C. D. C., Omeara, M., Campbell, N., Wang, J. S., Cetinbas, M., Lang, A., Ausk, B. J., Brooks, D. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17099-3 · Cited by 86
Cell adhesion molecules in fibrotic diseases
Hu, Q., Saleem, K., Pandey, J., Charania, A. N., Zhou, Y., & He, C. (2023) · Biomedicines · doi:10.3390/biomedicines11071995 · Cited by 32
Metadata
- Authors
- Kapp, T. G., Rechenmacher, F., Neubauer, S., Maltsev, O. V., Cavalcanti-Adam, E. A., Zarka, R., Reuning, U., Notni, J., Wester, H.-J., Mas-Moruno, C., Spatz, J., Geiger, B., & Kessler, H.
- Venue
- Scientific Reports
- Published
- 2017-01-11
- Volume
- 7
- Issue
- 1
- Pages
- 39805-39805
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2578530566
- Cited by
- 620
- References
- 89
- FWCI
- 34.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.